| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/01/2004 | US20040063922 Ester interchange; autocatalyst; genetic engineering; gene therapy for genetic disorders |
| 04/01/2004 | US20040063917 Modified erythropoietin (epo) with reduced immunogenicity |
| 04/01/2004 | US20040063914 Antibodies against phosphorylated VASP ( vasodilator-stimulated phosphoprotein), hybridoma cells for their preparation, and their use |
| 04/01/2004 | US20040063913 Antibodies to human il-1beta |
| 04/01/2004 | US20040063908 Comprises genetically engineered hemophilus adherence and penetration (HAP) proteins for treatment and prevention of influenza; immunotherapy |
| 04/01/2004 | US20040063907 Gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 04/01/2004 | US20040063906 Peptide nucleic acid sequences; antibodies for controlling disease; bactericides, viricides |
| 04/01/2004 | US20040063905 Armed peptides |
| 04/01/2004 | US20040063735 Calcitonin gene related peptide receptor antagonists |
| 04/01/2004 | US20040063657 Antisense modulation of phosphoinositide-3-kinase, regulatory subunit 4, P150 expression |
| 04/01/2004 | US20040063655 Antisense modulation of transforming growth factor-beta expression |
| 04/01/2004 | US20040063654 Attenuating expression of target gene in vivo; altering cell growth, survival and/or differentiation; stable respiratory formulation for pulmonary or nasal delivery |
| 04/01/2004 | US20040063652 Introducing multiple nucleic acid molecules simultaneously without deletereous effects; controlling level of expression |
| 04/01/2004 | US20040063639 Storage stable buffered liquid and lyophilized materials |
| 04/01/2004 | US20040063635 Recombinant human albumin fusion proteins with long-lasting biological effects |
| 04/01/2004 | US20040063634 Modified kertinocyte growth factor (kgf) with reduced immunogenicity |
| 04/01/2004 | US20040063632 Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants |
| 04/01/2004 | US20040063621 Heterocarpine, a human ghrh-binding protein |
| 04/01/2004 | US20040063617 Expressing a nucleic acid encoding protein selected from lactoferrin protein and lysozyme protein in a monocot seed; isolating protein from the seed, combining with carrier diluent to provide formulation for oral administration |
| 04/01/2004 | US20040063614 For therapy of brain diseases |
| 04/01/2004 | US20040063207 Recombinational cloning using nucleic acids having recombination sites |
| 04/01/2004 | US20040063201 Controlling lineage development in an in vitro human tissue system for bone marrow transplantation |
| 04/01/2004 | US20040063191 Compositions and methods for determining the replication capacity of a pathogenic virus |
| 04/01/2004 | US20040063188 Kit for treating gastrointestinal tract |
| 04/01/2004 | US20040063186 Vectors and methods for recombinant protein expression |
| 04/01/2004 | US20040063182 Process for producing prenyl alcohol |
| 04/01/2004 | US20040063181 Process for the preparation of L-amino acids using a gene encoding 6-phosphogluconate dehydrogenase |
| 04/01/2004 | US20040063180 Comprises nucleotide sequences coding lysine biosynthetic polypeptide for transforming coryneform bacteria and fermentation of lysine; animal feeds and medicine |
| 04/01/2004 | US20040063179 Novel potassium channel molecules and uses therefor |
| 04/01/2004 | US20040063178 Comprises enzymatic polypeptide for identifying modulators of leukocyte adhesion and treatments of inflammatory diseases l |
| 04/01/2004 | US20040063177 Generating subtilisin mutant with decreased immunogenicity for use in laundry detergents, cosmetics and textile treatment |
| 04/01/2004 | US20040063176 Compositions, methods and kits relating to remodel |
| 04/01/2004 | US20040063175 Transgenic cell for preparation of monatin; food and beverage sweetening |
| 04/01/2004 | US20040063174 Comprises nucleotide sequences coding allelic cyclase for identifying modulators which prevent, ameliorate or correct dysfunction or diseases of central nervous and urogenital systems |
| 04/01/2004 | US20040063171 Genetic engineered microroganisms; auxotropic mutants; polynucleotide sequences |
| 04/01/2004 | US20040063164 Kit and method for detecting the esm-1 protein |
| 04/01/2004 | US20040063155 Using subtilisin to target preferential nucleotide sequences and diagnose viral and parasitic infections |
| 04/01/2004 | US20040063150 Preparation of microarrays comprising magnetizable, locally defined, temporarily bound, solid phase supports which are immobilized to a common base support in order to characterize individual compounds and monitor molecular interactions |
| 04/01/2004 | US20040063144 Multiple displacement amplification |
| 04/01/2004 | US20040063143 Comprises nucleotide sequences coding enzymatic polypeptides associated with steroid, carotenoids and squalene biosynthesis |
| 04/01/2004 | US20040063142 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins and uses thereof |
| 04/01/2004 | US20040063141 Cell surface display of proteins by recombinant host cells |
| 04/01/2004 | US20040063140 Methods for diagnosis of cancer using erbB-3 |
| 04/01/2004 | US20040063139 Comprises using nucleotide sequences coding deoxyguanosine triphosphate triphosphophydrolase to detect microorganisms in water supply |
| 04/01/2004 | US20040063138 Polynucleotide sequencing method |
| 04/01/2004 | US20040063135 Comprises oligonucleotides for determining concentration of glucuonidase in cell culture; detection and monitoring of malignancies and metastasis; targeted drug delivery |
| 04/01/2004 | US20040063134 Novel isoforms of human pregnancy-associated protein-E |
| 04/01/2004 | US20040063132 Comprises uterine myometrium lieomya receptor (UMLR) protein for diagnosis, prevention and treatment of cell proliferative disorders; antitumor agents |
| 04/01/2004 | US20040063131 Comprises neuroendocrine-specific proteins-like polypeptides (NSPLP) for diagnosis, prevention and treatment of neurodegenerative and cell proliferative diseases |
| 04/01/2004 | US20040063129 Comprises oligonucleotides associated with inhibition of peroxisome proliferator activated receptors (PPAR) gene activity for treating cancer, osteoporosis, diabetes and endocrine disorders; gene expression inhibition |
| 04/01/2004 | US20040063127 Comprises nuclelotide sequences coding cytokine for diagnosis, prevention and treatment of infection, hepatitis, nephritis, cancer and autoimmune diseases |
| 04/01/2004 | US20040063126 Electrochemical sensor using intercalative, redox-active moieties |
| 04/01/2004 | US20040063125 Transgenic cells coding membrane protein which controls intracellular hydrogen ion concentration for identifying modulators for treatment of diabetes |
| 04/01/2004 | US20040063122 Method for separating and purifying a nucleic acid |
| 04/01/2004 | US20040063121 Method for separating and purifying a nucleic acid |
| 04/01/2004 | US20040063111 Method for protecting personal information |
| 04/01/2004 | US20040063110 Novel probes for the detection of mycobacteria |
| 04/01/2004 | US20040063109 Apparatus for monitoring allelic discrimination and/or gene expression analysis and subsequent storage on computer medium |
| 04/01/2004 | US20040063097 Nanomachine compositions and methods of use |
| 04/01/2004 | US20040063096 Oligonucleotides and method for characterizing and detecting genogroup II type small round structured virus |
| 04/01/2004 | US20040063095 gM-negative EHV-mutants |
| 04/01/2004 | US20040063094 Mutant herpes simplex viruses and uses thereof |
| 04/01/2004 | US20040063092 Immunoassays for anti-HCV antibodies |
| 04/01/2004 | US20040063088 Analyzing effect of antitumor agents on tumorous breast tissue |
| 04/01/2004 | US20040062777 Genetic engineered polypeptides; enzyme inhibitors |
| 04/01/2004 | US20040062769 Identification of the domain of Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) that mediates adhesion to chondroitin sulfate A |
| 04/01/2004 | US20040062761 Nucleic acid and corresponding protein entitled 151P3D4 useful in treatment and detection of cancer |
| 04/01/2004 | US20040062756 Genetic engineering; hematopoietic or stem cells; binding lentivirus vector to cell surfaces |
| 04/01/2004 | US20040062752 Genetic engineered polynucleotide; antihemophilic factor; in situ administering to liver |
| 04/01/2004 | US20040062749 Modified granulocyte colony stimulating factor (g-csf) with reduced immunogenicity |
| 04/01/2004 | US20040062712 Methods of screening agents for activity using teleosts |
| 04/01/2004 | US20040061858 In-situ detection and analysis of methane in coal bed methane formations with spectrometers |
| 04/01/2004 | US20040060568 Hedgehog antagonists, methods and uses related thereto |
| 04/01/2004 | DE10244842A1 Für proteinspaltende Enzyme in Form von spezifischen Proteasen kodierende Nukleinsäuresequenzen, zugehörige Polypeptide und Verwendung von allen For protein-splitting enzymes in the form of specific proteases coding nucleic acid sequences associated polypeptides and use of all |
| 04/01/2004 | DE10244457A1 Verfahren zur rationalen Mutagenese von alpha/beta T-Zell Rezeptoren und entsprechend mutierte MDM2-Protein spezifische alpha/beta T-Zell Rezeptoren A process for the rational mutagenesis of alpha / beta T-cell receptors and corresponding mutant MDM2 protein specific alpha / beta T-cell receptors |
| 04/01/2004 | DE10244347A1 Preparation of N-carbamoylamino acid, useful as intermediate in enantioselective synthesis of amino acids, by enzymatic hydrolysis of the corresponding amide |
| 04/01/2004 | CA2833202A1 Compstatin analogs with improved activity |
| 04/01/2004 | CA2499996A1 Triplex hairpin ribozyme |
| 04/01/2004 | CA2499770A1 Riboswitches, methods for their use, and compositions for use with riboswitches. |
| 04/01/2004 | CA2499644A1 Process for producing ligand binding protein with the use of cell-free protein synthesis system and utilization thereof |
| 04/01/2004 | CA2499643A1 Lentiviral vector-mediated gene transfer and uses thereof |
| 04/01/2004 | CA2499628A1 Combination treatment of cancer using a cancer vaccine and a chemotherapeutic drug |
| 04/01/2004 | CA2499522A1 Method of producing and screening antibodies produced in transgenic plants |
| 04/01/2004 | CA2499470A1 Animal immunocontraceptives expressed in plants and uses thereof |
| 04/01/2004 | CA2499467A1 Methods for increasing the production of a recombinant polypeptide from a host cell |
| 04/01/2004 | CA2499390A1 Kits and methods for assessing skin health |
| 04/01/2004 | CA2499385A1 Modified adenoviral vectors for use in vaccines and gene therapy |
| 04/01/2004 | CA2499375A1 Biological containment system |
| 04/01/2004 | CA2498713A1 Real-time detection of nucleic acid reactions |
| 04/01/2004 | CA2498604A1 Live antenuated parasite vaccine |
| 04/01/2004 | CA2498325A1 Prophylactic and therapeutic hiv aptamers |
| 04/01/2004 | CA2498164A1 Functional correction of the -786c/t- variance of the human enos-gene |
| 04/01/2004 | CA2497635A1 Transgenic expression cassettes for expressing nucleic acids in non-reproductive flower tissues of plants |
| 04/01/2004 | CA2497554A1 Immunotherapeutic compositions and methods for the treatment of moderately to well-differentiated cancers |
| 04/01/2004 | CA2496687A1 Ghrh analogues |
| 04/01/2004 | CA2496300A1 Transgenic expression cassettes for the expression of nucleic acids in plant blooms |
| 04/01/2004 | CA2483624A1 Improved raav expression systems for genetic modification of specific capsid proteins |
| 04/01/2004 | CA2474680A1 Method for analyzing organelle-localized protein and material for analysis |
| 04/01/2004 | CA2443463A1 Concentrate of a factor viii:c-containing von willebrand factor and the process relating thereto |
| 03/31/2004 | EP1403641A1 Method of calculating association and dissociation constants using a polymer chip for identifying ionic polymers |